FOXO Current Deferred Revenue from 2010 to 2024
| FOXO Stock | USD 0.42 0.04 8.91% |
Check FOXO Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among FOXO Technologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 8.83, Dividend Yield of 0.0 or Days Sales Outstanding of 57.14. FOXO financial statements analysis is a perfect complement when working with FOXO Technologies Valuation or Volatility modules.
FOXO | Current Deferred Revenue |
About FOXO Technologies Financial Statements
FOXO Technologies investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how FOXO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company was founded in 2019 and is based in Minneapolis, Minnesota. Foxo Technologies operates under Health Information Services classification in the United States and is traded on AMEX Exchange. It employs 82 people.
Pair Trading with FOXO Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if FOXO Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FOXO Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with FOXO Stock
Moving against FOXO Stock
| 0.63 | DRIO | DarioHealth Corp | PairCorr |
| 0.58 | VERO | Venus Concept | PairCorr |
| 0.56 | EDAP | EDAP TMS SA | PairCorr |
| 0.32 | CI | Cigna Corp | PairCorr |
The ability to find closely correlated positions to FOXO Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace FOXO Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back FOXO Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling FOXO Technologies to buy it.
The correlation of FOXO Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FOXO Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FOXO Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for FOXO Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of FOXO Technologies Correlation against competitors. To learn how to invest in FOXO Stock, please use our How to Invest in FOXO Technologies guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FOXO Technologies. If investors know FOXO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FOXO Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.05 | Revenue Per Share 0.02 | Quarterly Revenue Growth 1.333 | Return On Assets (1.14) | Return On Equity (17.55) |
The market value of FOXO Technologies is measured differently than its book value, which is the value of FOXO that is recorded on the company's balance sheet. Investors also form their own opinion of FOXO Technologies' value that differs from its market value or its book value, called intrinsic value, which is FOXO Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FOXO Technologies' market value can be influenced by many factors that don't directly affect FOXO Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FOXO Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if FOXO Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FOXO Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.